Tag: INDIAN PHARMA NEWS
Government Panel Recommends Keeping Doorstep Medicine Delivery Rule with Stricter Enforcement
A government sub-committee has recommended retaining the doorstep medicine delivery notification 2020, despite objections from The All-India Organisation of Chemists and Druggists (AIOCD), which argued the rule was...
Supreme Court of India Refuses to Quash CBI Complaint Against Sanofi India in BARC Procurement Case
The Supreme Court dismissed an appeal filed by Sanofi India Limited, refusing to quash criminal proceedings arising from a CBI chargesheet. The court ruled that...
Novartis India’s Strategic Hypertension Play: ₹1,250 Crore for Pfizer’s Minipress Takeover
ChrysCapital-backed Novartis India has acquired Pfizer's Minipress and Minipres trademarks for Rs 1,250 crore, marking a significant expansion of its cardiovascular portfolio. The acquisition, approved by Novartis...
Lupin Receives U.S. FDA Approval for Modafinil Tablets USP Across 100 mg and 200 mg Strengths
Lupin Limited announced that it has received final approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application...
ILS Hospitals Raipur Achieves Major Clinical Milestone with Successful Completion of Its First Liver Transplant
ILS Hospitals, Raipur, in clinical collaboration with Star Hospitals, Hyderabad, has successfully performed its first liver transplant surgery at its Pachpedi Naka facility. The milestone represents...
DCGI Issues All-India Alert Over Counterfeit Abhayrab Vaccine Batch Following Failed CDL Kasauli Tests
Drug regulatory bodies and law enforcement agencies have intensified coordinated enforcement actions against the illegal manufacture and distribution of misbranded and spurious medicines, leading...
